The WHO recommends treatment of HIV infection with combination anti-retroviral therapy regardless of CD4+ T- cell count, however, therapeutic benefit of HAART alone on HIV-PAH is a contentious topic requiring further research. This evidence concerns the gene CD4 and HIV infectious disease.